The World Market for Antibiotics Excluding Medicaments: A 2009 Global Trade Perspective
ICON Group International, January 2009, Pages: 201
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for antibiotics excluding medicaments. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for antibiotics excluding medicaments for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying antibiotics excluding medicaments? What is the dollar value of these imports? How much do the imports of antibiotics excluding medicaments vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of antibiotics excluding medicaments? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported antibiotics excluding medicaments. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of antibiotics excluding medicaments, for each individual country. Chapter 4 does the same, but for imports of antibiotics excluding medicaments for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of antibiotics excluding medicaments to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in antibiotics excluding medicaments (i.e. their market shares are close or equal to zero percent). "Antibiotics Excluding Medicaments" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "antibiotics excluding medicaments" is 5413 . For more information on this definition, please refer to the following web site:
http://unstats.un.org/unsd/cr/registry/regcs.asp?Cl=14&Lg=1&Co=541 .
Important Caveat. The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for the current year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, "mad cow" disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the "net loss" or "net gain" due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.
Related Reports. This report was created for the market for antibiotics excluding medicaments. Closely related reports published by ICON Group include the following:
The World Market for Antibiotics Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Ephedrines and Their Salts: A 2009 Global Trade Perspective
The World Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products: A 2009 Global Trade Perspective
The World Market for Medicaments Containing Antibiotics or Their Derivatives: A 2009 Global Trade Perspective
The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2009 Global Trade Perspective
The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Pharmaceutical Goods Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Provitamins and Vitamins Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Rye Ergot Alkaloids, Their Derivatives, and Salts Thereof: A 2009 Global Trade Perspective
The World Market for Vegetable Alkaloids and Their Salts, Ethers, Esters and Other Derivatives Excluding Medicaments: A 2009 Global Trade Perspective
1 METHODOLOGY 10
1.1 Our Approach 10
2 THE WORLD MARKET 13
2.1 Exports 13
2.1.1 The World Market: Antibiotics Excluding Medicaments Export Supplies in 2009 13
2.2 Imports 15
2.2.1 The World Market: Imported Antibiotics Excluding Medicaments in 2009 15
3 EXPORTS 19
3.1 Africa: Export Supplies of Antibiotics Excluding Medicaments 19
3.1.1 Executive Summary 19
3.1.2 Algeria 21
3.1.3 Egypt 22
3.1.4 Mauritius 22
3.1.5 Sierra Leone 23
3.1.6 South Africa 23
3.1.7 Tunisia 23
3.1.8 Zimbabwe 24
3.2 Asia: Export Supplies of Antibiotics Excluding Medicaments 24
3.2.1 Executive Summary 24
3.2.2 Bangladesh 26
3.2.3 China 27
3.2.4 Hong Kong 28
3.2.5 India 29
3.2.6 Indonesia 30
3.2.7 Japan 31
3.2.8 Macau 32
3.2.9 Malaysia 33
3.2.10 Nepal 33
3.2.11 North Korea 34
3.2.12 Philippines 34
3.2.13 Singapore 35
3.2.14 South Korea 36
3.2.15 Sri Lanka 37
3.2.16 Taiwan 37
3.2.17 Thailand 38
3.2.18 Vietnam 38
3.3 Europe: Export Supplies of Antibiotics Excluding Medicaments 39
3.3.1 Executive Summary 39
3.3.2 Austria 42
3.3.3 Belgium 43
3.3.4 Bosnia and Herzegovina 44
3.3.5 Bulgaria 45
3.3.6 Croatia 46
3.3.7 Cyprus 46
3.3.8 Czech Republic 47
3.3.9 Denmark 48
3.3.10 France 49
3.3.11 Germany 50
3.3.12 Gibraltar 51
3.3.13 Greece 51
3.3.14 Hungary 52
3.3.15 Iceland 53
3.3.16 Ireland 54
3.3.17 Italy 55
3.3.18 Luxembourg 56
3.3.19 Norway 57
3.3.20 Poland 58
3.3.21 Portugal 59
3.3.22 Romania 60
3.3.23 Russia 61
3.3.24 Serbia and Montenegro 61
3.3.25 Slovakia 62
3.3.26 Slovenia 63
3.3.27 Spain 64
3.3.28 Sweden 65
3.3.29 Switzerland 66
3.3.30 the Netherlands 67
3.3.31 the United Kingdom 68
3.3.32 Ukraine 69
3.4 Latin America: Export Supplies of Antibiotics Excluding Medicaments 69
3.4.1 Executive Summary 69
3.4.2 Argentina 71
3.4.3 Brazil 72
3.4.4 Chile 72
3.4.5 Colombia 73
3.4.6 Costa Rica 73
3.4.7 Ecuador 73
3.4.8 El Salvador 73
3.4.9 Guatemala 74
3.4.10 Honduras 74
3.4.11 Mexico 75
3.4.12 Panama 76
3.4.13 Peru 76
3.4.14 Uruguay 76
3.5 North America & the Caribbean: Export Supplies of Antibiotics Excluding Medicaments 76
3.5.1 Executive Summary 76
3.5.2 Canada 79
3.5.3 the United States 80
3.6 Oceana: Export Supplies of Antibiotics Excluding Medicaments 81
3.6.1 Executive Summary 81
3.6.2 Australia 83
3.6.3 New Zealand 84
3.7 the Middle East: Export Supplies of Antibiotics Excluding Medicaments 84
3.7.1 Executive Summary 84
3.7.2 Iran 86
3.7.3 Israel 87
3.7.4 Jordan 88
3.7.5 Oman 89
3.7.6 Pakistan 90
3.7.7 Qatar 90
3.7.8 Saudi Arabia 90
3.7.9 Syrian Arab Republic 90
3.7.10 the United Arab Emirates 91
3.7.11 Turkey 92
3.7.12 Yemen 92
4 IMPORTS 93
4.1 Africa: Antibiotics Excluding Medicaments Imports in 2009 93
4.1.1 Executive Summary 93
4.1.2 Algeria 96
4.1.3 Cameroon 97
4.1.4 Cape Verde 97
4.1.5 Egypt 98
4.1.6 Ghana 99
4.1.7 Kenya 100
4.1.8 Madagascar 100
4.1.9 Mauritius 101
4.1.10 Morocco 101
4.1.11 Senegal 102
4.1.12 South Africa 103
4.1.13 Sudan 104
4.1.14 Tanzania 104
4.1.15 Tunisia 105
4.1.16 Uganda 106
4.1.17 Zambia 106
4.1.18 Zimbabwe 107
4.2 Asia: Antibiotics Excluding Medicaments Imports in 2009 107
4.2.1 Executive Summary 107
4.2.2 Bangladesh 111
4.2.3 Cambodia 112
4.2.4 China 112
4.2.5 Hong Kong 113
4.2.6 India 114
4.2.7 Indonesia 115
4.2.8 Japan 116
4.2.9 Macau 117
4.2.10 Malaysia 118
4.2.11 Philippines 119
4.2.12 Seychelles 120
4.2.13 Singapore 121
4.2.14 South Korea 122
4.2.15 Sri Lanka 123
4.2.16 Taiwan 124
4.2.17 Thailand 125
4.3 Europe: Antibiotics Excluding Medicaments Imports in 2009 126
4.3.1 Executive Summary 126
4.3.2 Albania 129
4.3.3 Austria 130
4.3.4 Belarus 131
4.3.5 Belgium 132
4.3.6 Bosnia and Herzegovina 132
4.3.7 Bulgaria 133
4.3.8 Croatia 133
4.3.9 Cyprus 134
4.3.10 Czech Republic 135
4.3.11 Denmark 136
4.3.12 Estonia 136
4.3.13 Finland 137
4.3.14 France 138
4.3.15 Georgia 139
4.3.16 Germany 140
4.3.17 Greece 141
4.3.18 Hungary 142
4.3.19 Iceland 142
4.3.20 Ireland 143
4.3.21 Italy 144
4.3.22 Lithuania 145
4.3.23 Luxembourg 145
4.3.24 Macedonia 145
4.3.25 Malta 146
4.3.26 Moldova 146
4.3.27 Norway 147
4.3.28 Poland 148
4.3.29 Portugal 149
4.3.30 Romania 150
4.3.31 Russia 151
4.3.32 Serbia and Montenegro 152
4.3.33 Slovakia 153
4.3.34 Slovenia 154
4.3.35 Spain 155
4.3.36 Sweden 156
4.3.37 Switzerland 157
4.3.38 the Netherlands 158
4.3.39 the United Kingdom 159
4.3.40 Ukraine 160
4.4 Latin America: Antibiotics Excluding Medicaments Imports in 2009 160
4.4.1 Executive Summary 160
4.4.2 Argentina 164
4.4.3 Bolivia 165
4.4.4 Brazil 166
4.4.5 Chile 167
4.4.6 Colombia 168
4.4.7 Costa Rica 169
4.4.8 Ecuador 170
4.4.9 El Salvador 171
4.4.10 Guatemala 172
4.4.11 Guyana 172
4.4.12 Mexico 173
4.4.13 Nicaragua 174
4.4.14 Paraguay 174
4.4.15 Peru 175
4.4.16 Uruguay 176
4.4.17 Venezuela 177
4.5 North America & the Caribbean: Antibiotics Excluding Medicaments Imports in 2009 178
4.5.1 Executive Summary 178
4.5.2 Canada 181
4.5.3 the United States 182
4.6 Oceana: Antibiotics Excluding Medicaments Imports in 2009 183
4.6.1 Executive Summary 183
4.6.2 Australia 186
4.6.3 New Zealand 187
4.7 the Middle East: Antibiotics Excluding Medicaments Imports in 2009 187
4.7.1 Executive Summary 187
4.7.2 Iran 191
4.7.3 Israel 192
4.7.4 Jordan 193
4.7.5 Lebanon 194
4.7.6 Oman 194
4.7.7 Pakistan 195
4.7.8 Qatar 196
4.7.9 Saudi Arabia 196
4.7.10 Syrian Arab Republic 197
4.7.11 Turkey 198
4.7.12 Yemen 199
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 200
5.1 Disclaimers & Safe Harbor 200
5.2 ICON Group Ltd. User Agreement Provisions 201
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
